Tau, amyloid, and hypometabolism in a patient with posterior cortical atrophy

Rik Ossenkoppele, Daniel R. Schonhaut, Suzanne L. Baker, James P. O’Neil, Mustafa Janabi, Pia Ghosh, Miguel Santos‐Santos, Zachary Miller, Brianne M. Bettcher, Maria Luisa Gorno‐Tempini, Bruce L. Miller, William J. Jagust, Gil D. RabinoviciAnnals 2014 · DOI

Abstract

Determining the relative contribution of amyloid plaques and neurofibrillary tangles to brain dysfunction in Alzheimer disease is critical for therapeutic approaches, but until recently could only be assessed at autopsy. We report a patient with posterior cortical atrophy (visual variant of Alzheimer disease) who was studied using the novel tau tracer [(18) F]AV-1451 in conjunction with [(11) C]Pittsburgh compound B (PIB; amyloid) and [(18) F]fluorodeoxyglucose (FDG) positron emission tomography. Whereas [(11) C]PIB bound throughout association neocortex, [(18) F]AV-1451 was selectively retained in posterior brain regions that were affected clinically and showed markedly reduced [(18) F]FDG uptake. This provides preliminary in vivo evidence that tau is more closely linked to hypometabolism and symptomatology than amyloid.
BibTeX
@article{ossenkoppele2014tau,
  author = {Rik Ossenkoppele and Daniel R. Schonhaut and Suzanne L. Baker and James P. O’Neil and Mustafa Janabi and Pia Ghosh and Miguel Santos‐Santos and Zachary Miller and Brianne M. Bettcher and Maria Luisa Gorno‐Tempini and Bruce L. Miller and William J. Jagust and Gil D. Rabinovici},
  title = {{Tau, amyloid, and hypometabolism in a patient with posterior cortical atrophy}},
  journal = {Annals},
  year = {2014},
  doi = {10.1002/ana.24321},
}

Loading related content...

Figure